133 related articles for article (PubMed ID: 11382539)
1. Phospholipid abnormalities in postmortem schizophrenic brains detected by 31P nuclear magnetic resonance spectroscopy: a preliminary study.
Komoroski RA; Pearce JM; Griffin WS; Mrak RE; Omori M; Karson CN
Psychiatry Res; 2001 May; 106(3):171-80. PubMed ID: 11382539
[TBL] [Abstract][Full Text] [Related]
2. 31P NMR spectroscopy of phospholipid metabolites in postmortem schizophrenic brain.
Komoroski RA; Pearce JM; Mrak RE
Magn Reson Med; 2008 Mar; 59(3):469-74. PubMed ID: 18306399
[TBL] [Abstract][Full Text] [Related]
3. Phospholipid composition of postmortem schizophrenic brain by 31P NMR spectroscopy.
Pearce JM; Komoroski RA; Mrak RE
Magn Reson Med; 2009 Jan; 61(1):28-34. PubMed ID: 19097198
[TBL] [Abstract][Full Text] [Related]
4. Altered phospholipid metabolism in schizophrenia: a phosphorus 31 nuclear magnetic resonance spectroscopy study.
Weber-Fahr W; Englisch S; Esser A; Tunc-Skarka N; Meyer-Lindenberg A; Ende G; Zink M
Psychiatry Res; 2013 Dec; 214(3):365-73. PubMed ID: 24045051
[TBL] [Abstract][Full Text] [Related]
5. 31P magnetic resonance spectroscopy studies in schizophrenia.
Williamson PC; Brauer M; Leonard S; Thompson T; Drost D
Prostaglandins Leukot Essent Fatty Acids; 1996 Aug; 55(1-2):115-8. PubMed ID: 8888133
[TBL] [Abstract][Full Text] [Related]
6. Frontal lobe membrane phospholipid metabolism and ventricle to brain ratio in schizophrenia: preliminary 31P-MRS and CT studies.
Shioiri T; Hamakawa H; Kato T; Fujii K; Murashita J; Inubushi T; Someya T
Eur Arch Psychiatry Clin Neurosci; 2000; 250(4):169-74. PubMed ID: 11009069
[TBL] [Abstract][Full Text] [Related]
7. 31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism.
Yacubian J; de Castro CC; Ometto M; Barbosa E; de Camargo CP; Tavares H; Cerri GG; Gattaz WF
Schizophr Res; 2002 Dec; 58(2-3):117-22. PubMed ID: 12409151
[TBL] [Abstract][Full Text] [Related]
8. Analysis of phospholipid molecular species in brain by (31)P NMR spectroscopy.
Pearce JM; Komoroski RA
Magn Reson Med; 2000 Aug; 44(2):215-23. PubMed ID: 10918320
[TBL] [Abstract][Full Text] [Related]
9. Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients.
Yao JK; Leonard S; Reddy RD
Schizophr Res; 2000 Mar; 42(1):7-17. PubMed ID: 10706981
[TBL] [Abstract][Full Text] [Related]
10. Resolution of phospholipid molecular species by 31P NMR.
Pearce JM; Komoroski RA
Magn Reson Med; 1993 Jun; 29(6):724-31. PubMed ID: 8350715
[TBL] [Abstract][Full Text] [Related]
11. Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla.
Jensen JE; Miller J; Williamson PC; Neufeld RW; Menon RS; Malla A; Manchanda R; Schaefer B; Densmore M; Drost DJ
Psychiatry Res; 2006 Mar; 146(2):127-35. PubMed ID: 16497488
[TBL] [Abstract][Full Text] [Related]
12. Neurochemical investigation of the schizophrenic brain by in vivo phosphorus magnetic resonance spectroscopy.
Fukuzako H
World J Biol Psychiatry; 2001 Apr; 2(2):70-82. PubMed ID: 12587188
[TBL] [Abstract][Full Text] [Related]
13. 31phosphorus magnetic resonance spectroscopy of the frontal and parietal lobes in chronic schizophrenia.
Deicken RF; Calabrese G; Merrin EL; Meyerhoff DJ; Dillon WP; Weiner MW; Fein G
Biol Psychiatry; 1994 Oct; 36(8):503-10. PubMed ID: 7827212
[TBL] [Abstract][Full Text] [Related]
14. 31P-MR spectroscopy in children and adolescents with a familial risk of schizophrenia.
Rzanny R; Klemm S; Reichenbach JR; Pfleiderer SO; Schmidt B; Volz HP; Blanz B; Kaiser WA
Eur Radiol; 2003 Apr; 13(4):763-70. PubMed ID: 12664115
[TBL] [Abstract][Full Text] [Related]
15. Multiple regression analysis of relationship between frontal lobe phosphorus metabolism and clinical symptoms in patients with schizophrenia.
Shioiri T; Someya T; Murashita J; Kato T; Hamakawa H; Fujii K; Inubushi T
Psychiatry Res; 1997 Dec; 76(2-3):113-22. PubMed ID: 9522403
[TBL] [Abstract][Full Text] [Related]
16. Metabolic mapping using 2D 31P-MR spectroscopy reveals frontal and thalamic metabolic abnormalities in schizophrenia.
Smesny S; Rosburg T; Nenadic I; Fenk KP; Kunstmann S; Rzanny R; Volz HP; Sauer H
Neuroimage; 2007 Apr; 35(2):729-37. PubMed ID: 17276699
[TBL] [Abstract][Full Text] [Related]
17. [Phosphorus 31 magnetic resonance spectroscopy in schizophrenia research. Pathophysiology of cerebral metabolism of high-energy phosphate and membrane phospholipids].
Riehemann S; Volz HP; Smesny S; Hübner G; Wenda B; Rössger G; Sauer H
Nervenarzt; 2000 May; 71(5):354-63. PubMed ID: 10846710
[TBL] [Abstract][Full Text] [Related]
18. Distribution of membrane phospholipids in the rabbit uvea.
Greiner JV; Leahy CD; Glonek T
Ophthalmic Res; 1995; 27(5):277-85. PubMed ID: 8552368
[TBL] [Abstract][Full Text] [Related]
19. Quantitative proton-decoupled 31P MRS of the schizophrenic brain in vivo.
Blüml S; Tan J; Harris K; Adatia N; Karme A; Sproull T; Ross B
J Comput Assist Tomogr; 1999; 23(2):272-5. PubMed ID: 10096336
[TBL] [Abstract][Full Text] [Related]
20. Reduced phosphodiesters and high-energy phosphates in the frontal lobe of schizophrenic patients: a (31)P chemical shift spectroscopic-imaging study.
Volz HR; Riehemann S; Maurer I; Smesny S; Sommer M; Rzanny R; Holstein W; Czekalla J; Sauer H
Biol Psychiatry; 2000 Jun; 47(11):954-61. PubMed ID: 10838063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
